NCT03534310View on ClinicalTrials.gov

Weight Loss With Intensive Lifestyle Modifications Plus Bariatric Surgery Versus Liraglutide 3 mg

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

November 2, 2015

Primary Completion Date

January 31, 2017

Study Completion Date

April 10, 2017

Conditions
Obesity
Interventions
DRUG

LIRAGLUTIDE 3 Mg/0.5 mL (18 Mg/3 mL) SUB-Q PEN INJECTOR (ML)

OTHER

lifestyle modification

OTHER

sleeve gastrectomy

Trial Locations (1)

00168

Catholic University School of Medicine, Rome

All Listed Sponsors
lead

Catholic University of the Sacred Heart

OTHER

NCT03534310 - Weight Loss With Intensive Lifestyle Modifications Plus Bariatric Surgery Versus Liraglutide 3 mg | Biotech Hunter | Biotech Hunter